Aerovate Therapeutics, Inc.

NASDAQ:AVTE

2.68 (USD) • At close April 25, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -69.628-75.521-51.511-22.963-9.611-3.33
Depreciation & Amortization 0.2820.0960.0680.0150.0010
Deferred Income Tax 000000
Stock Based Compensation 11.31111.9065.4762.0430.0580
Change In Working Capital -8.9979.7987.755-6.510.9740.549
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0-0.1641.3680.6090.0370.436
Other Working Capital -8.9979.9626.387-7.1190.9370.113
Other Non Cash Items -4.164-3.057-0.910.0160.719-0.436
Operating Cash Flow -71.196-56.778-39.122-27.399-7.859-2.781
Investing Activities:
Investments In Property Plant And Equipment 0-0.142-0.195-0.18100
Acquisitions Net 00-0.007000
Purchases Of Investments 0-123.982-147.623-113.25300
Sales Maturities Of Investments 0136154.744000
Other Investing Activites 56.02900.007-0.11300
Investing Cash Flow 56.02911.8766.926-113.43400
Financing Activities:
Debt Repayment 00002.50
Common Stock Issued 23.94244.8880.15126.9456.4180
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 1.4852.2160.39663.51212.8312.5
Financing Cash Flow 25.42745.9960.396190.4578.9182.5
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash 10.261.094-31.849.6241.059-0.281
Cash At End Of Period 33.75123.49122.39754.1974.5733.514